Nair Vinay’s Idexx Laboratories IDXX Stock Holding History

Nair Vinay’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,106	Closed	-$394K	–	243
2015 Q1	$394K	Sell	5,106 -62	-1%	-$4.83K	0.27%	112
2014 Q4	$383K	Buy	+5,168	New	+$362K	0.47%	63

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nair Vinay's IDXX Position: Q2 2015 in Review

Nair Vinay sold out of Idexx Laboratories (IDXX) in Q2 2015, closing a stake of 5,106 shares — an estimated $394K sold.

Nair Vinay first reported a position in IDXX in Q4 2014 and held it in 2 quarters. The position peaked at $394K in Q1 2015. 348 funds tracked by Wall St. Rank hold IDXX as of Q2 2015.

Nair Vinay reported no remaining Idexx Laboratories position as of Q2 2015 after selling out during the quarter.
Nair Vinay sold 5,106 Idexx Laboratories shares in Q2 2015, an estimated $394K.
Nair Vinay first reported a position in Idexx Laboratories in Q4 2014 and held it in 2 quarters.
Nair Vinay's Idexx Laboratories position peaked at $394K in Q1 2015.
348 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.